PRIMAXINIV (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the PRIMAXIN drug offered from Merck Sharp & Dohme Corp.. This Dipeptidase Inhibitors [MoA],Renal Dehydropeptidase Inhibitor [EPC],Carbapenems [Chemical/Ingredient],Penem Antibacterial [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
| NON-PROPRIETARY NAME: | imipenem and cilastatin sodium |
| SUBSTANCE NAME: | IMIPENEM; CILASTATIN SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Dipeptidase Inhibitors [MoA],Renal Dehydropeptidase Inhibitor [EPC],Carbapenems [Chemical/Ingredient],Penem Antibacterial [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1985-11-26 |
| END MARKETING DATE: | 0000-00-00 |
PRIMAXIN IV HUMAN PRESCRIPTION DRUG Details:
| Item Description | PRIMAXIN IV from Merck Sharp & Dohme Corp. |
| LABELER NAME: | Merck Sharp & Dohme Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 250; 250(mg/100mL; mg/100mL) |
| START MARKETING DATE: | 1985-11-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0006-3514_eedd8a01-302b-4c42-8d78-5fac2a2d2830 |
| PRODUCT NDC: | 0006-3514 |
| APPLICATION NUMBER: | NDA050587 |
Other IMIPENEM; CILASTATIN SODIUM Pharmaceutical Manufacturers / Labelers:
